
Next Genomix Laboratories is a high-complexity diagnostic laboratory specializing in pharmacogenomics, infectious disease pathogen detection, antimicrobial resistance, and small fiber peripheral neuropathy testing. The company leverages information technology and artificial intelligence to provide personalized laboratory data and precision guided reporting to healthcare providers, enabling actionable treatment recommendations and improved patient care. Their key products include Epidermal Nerve Fiber Density (ENFD) testing, Pharmacogenomics testing, Onychodystrophy testing, and Wound PCR testing. They serve healthcare practitioners in podiatry, primary care, neurology, and internal medicine, with transparent billing and in-network payor status, positioning them as a precision medicine leader in laboratory diagnostics.

Next Genomix Laboratories is a high-complexity diagnostic laboratory specializing in pharmacogenomics, infectious disease pathogen detection, antimicrobial resistance, and small fiber peripheral neuropathy testing. The company leverages information technology and artificial intelligence to provide personalized laboratory data and precision guided reporting to healthcare providers, enabling actionable treatment recommendations and improved patient care. Their key products include Epidermal Nerve Fiber Density (ENFD) testing, Pharmacogenomics testing, Onychodystrophy testing, and Wound PCR testing. They serve healthcare practitioners in podiatry, primary care, neurology, and internal medicine, with transparent billing and in-network payor status, positioning them as a precision medicine leader in laboratory diagnostics.